NCT03982212 2023-05-19
A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors
University of Kansas Medical Center
Phase 1 Unknown
University of Kansas Medical Center
Genzada Pharmaceuticals USA, Inc.
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
National Cancer Institute (NCI)